H340: Advisory Council on PANS & PANDAS. Latest Version

2021-2022

House
Passed 1st Reading
Committee
Rules
Passed 3rd Reading
Senate
Passed 1st Reading
Rules



AN ACT to establish an advisory council on pediatric acute‑onset neuropsychiatric syndrome (PANS) and pediatric autoimmune neuropsychiatric disorder associated with streptococcal infections (Pandas).

The General Assembly of North Carolina enacts:

SECTION 1.  Article 1B of Chapter 130A of the General Statutes is amended by adding a new section to read:

§ 130A‑33.52.  Advisory Council on Pediatric Acute‑Onset Neuropsychiatric Syndrome (PANS) and Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcal Infections (PANDAS); membership; terms; compensation; meetings; quorum.

(a)        There is established the Advisory Council on Pediatric Acute‑Onset Neuropsychiatric Syndrome (PANS) and Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcal Infections (PANDAS) within the Department to advise the Governor, the Secretary, and the General Assembly on research, diagnosis, treatment, and education relating to pediatric acute‑onset neuropsychiatric syndrome (PANS) and its subset, pediatric autoimmune neuropsychiatric disorder associated with streptococcal infections (PANDAS).

(b)        Advisory Council Membership.

(1)        The Secretary shall appoint members to the advisory council as follows, unless otherwise provided:

a.         A representative of a nonprofit pediatric acute‑onset neuropsychiatric syndrome advocacy organization.

b.         A representative of a professional organization for school psychologists or school social workers organized under the laws of this State.

c.         An osteopathic professional with experience treating persons with pediatric acute‑onset neuropsychiatric syndrome.

d.         An immunologist licensed and practicing in this State who has experience treating persons with pediatric acute‑onset neuropsychiatric syndrome and the use of intravenous immunoglobulin.

e.         A neurologist licensed and practicing in this State who has experience treating persons with pediatric acute‑onset neuropsychiatric syndrome.

f.          A pediatrician licensed and practicing in this State who has experience treating persons with pediatric acute‑onset neuropsychiatric syndrome.

g.         A child psychiatrist licensed and practicing in this State who has experience treating persons with pediatric acute‑onset neuropsychiatric syndrome.

h.         An employee of the North Carolina Department of Health and Human Services.

i.          A representative of an organization focused on autism.

j.          A nutrition expert with experience treating persons with pediatric acute‑onset neuropsychiatric syndrome.

k.         A parent with a child who has been diagnosed with pediatric acute‑onset neuropsychiatric syndrome.

l.          A representative of the State Board of Education with experience in special education.

m.        One member of the House of Representatives, appointed by the Speaker of the House.

n.         One member of the Senate, appointed by the President of the Senate.

(2)        The chairs of the Joint Legislative Oversight Committee on Health and Human Services, or the chairs' designees, shall serve on the advisory council. A member of the advisory council who is designated by the chairs of the Joint Legislative Oversight Committee on Health and Human Services may be a member of the General Assembly.

(3)        The Secretary, or the Secretary's designee, shall serve as an ex officio, nonvoting member of the advisory council.

(c)        Members appointed under subsection (b) of this section shall serve for a term of three years, and no member shall serve more than two consecutive terms.

(d)       Members of the advisory council shall receive per diem and necessary travel and subsistence expenses in accordance with the provisions of G.S. 138‑5 or G.S. 138‑6 or travel and subsistence expenses in accordance with the provisions of G.S. 120‑3.1, as applicable.

(e)        All administrative support and other services required by the advisory council shall be provided by the Department. Professional support shall be provided by the University of North Carolina School of Medicine.

(f)        The Secretary shall select the chair of the advisory council from among the members of the council.

(g)        The chair shall convene the first meeting of the advisory council no later than October 1, 2021. A majority of the council members shall constitute a quorum. A majority vote of a quorum shall be required for any official action of the advisory council. Following the first meeting, the advisory council shall meet upon the call of the chair or upon the request of a majority of council members.

(h)        All vacancies shall be filled by the original appointing officer of the seat that has become vacant within 30 days of the vacancy.

SECTION 2.  Article 1B of Chapter 130A of the General Statutes is amended by adding a new section to read:

§ 130A‑33.53.  Advisory Council on Pediatric Acute‑Onset Neuropsychiatric Syndrome (PANS) and Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcal Infections (PANDAS); powers and duties; reports.

The advisory council shall have the following powers and duties:

(1)        Advise on coordinating statewide efforts for the study of pediatric acute‑onset neuropsychiatric syndrome and its subset, pediatric autoimmune neuropsychiatric disorder associated with streptococcal infections, within the State.

(2)        File a report regarding pediatric acute‑onset neuropsychiatric syndrome and its subset, pediatric autoimmune neuropsychiatric disorder associated with streptococcal infections, to the Secretary, the Governor, and the Joint Legislative Oversight Committee on Health and Human Services on behalf of the General Assembly not later than January 15, 2022, and annually thereafter, on all of the following:

a.         The activities of the advisory council and its findings and recommendations.

b.         Up‑to‑date practice guidelines for diagnosis and treatment.

c.         Mechanisms to increase clinical awareness and education among physicians, including pediatricians, school‑based health centers, and providers of mental health services.

d.         Outreach to educators and parents to increase awareness.

e.         Development of a volunteer expert network to assist in education and outreach.

SECTION 3.  This act becomes effective July 1, 2021.